AstraZeneca-linked studies: OlympiaN, ZEAL and CHIO3 post results; two new studies registeredSep 25Weekly roundup, 7 itemsAstraZenecaAZD0120
AstraZeneca posts PASSAGE Phase 4 tezepelumab results; registers new prostate, lung, and NF2 trialsJul 17Weekly roundup, 6 itemsAstraZenecaosimertinib
Sign inSign in